Avista Healthcare Partners and Damier Group Acquire sanotact Group with Legal Counsel from White Case Kevin Warsh Appointed Fed Chair Pledges ReformOriented Agenda in SwearingIn Ceremony Streaming Platforms Gear Up for Weekend Content Drop Netflix Hulu Prime Video Apple TV and More Unveil New Releases OpenAI Signals Imminent Confidential IPO Filing Aiming to Lead AI Company Public Listings SpaceXs Potential 175 Trillion IPO Historical Patterns Suggest Possible Decline Market Sentiment Signals Caution Historical Patterns Suggest Potential Challenges Ahead Arrow Financial Q1 2026 Earnings EPS Beats Estimates by 176 IIIN Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick Pyxis Tankers PXS Q1 2026 Earnings EPS Surge Above Estimates Amid Strong Tanker Market BNGO Q1 2026 Earnings NarrowerthanExpected Loss Bolsters Investor Confidence EIC Q4 2025 Earnings Narrow EPS Miss Amid Steady Performance RingCentral Q1 2026 Earnings EPS Beats Estimates as Stock Rises 313 Charlton Aria Acquisition Corporation CHAR Holds Steady Near 1077 as SPAC Trading Remains Subdued Pediatrix Medical Group MD Holds Steady A Quiet Session Near Key Support Heico Corporation Holds Steady Near Key Support Amid Defensive Stability HEI Plum Acquisition Corp IV Unit PLMKU Edges Higher Tests Key Resistance Level Heartbeam Inc Warrants BEATW Rally 1077 as Price Hovers at Key Level Spotify CEO Defends AI Music Move as Alternative to Slop and Piracy MNST Q1 2026 Earnings Earnings Beat Estimates as EPS Surprises 833 Match Group MTCH Edges Lower as Shares Test Key Support Levels Acme United Corporation Navigates Narrow Range as Price Holds Steady Broadway Financial Corporation BYFC Gains 2 as Stock Approaches Key Resistance Captivision Inc CAPT Holds at 006 Amidst Minimal Trading Activity WF International Limited WXM Edges Higher Key Levels to Watch After 537 Gain RiverNorth Flexible Municipal Income Fund RFM Holds Steady as Municipal Bond Markets Consolidate Spring Valley Acquisition Corp IV Units SVIVU Hold Steady at 1026 Amid Low Volume Potential Support and Resistance Levels Define NearTerm Trading Range Royalty Pharma RPRX Edges Higher Testing Resistance Near 57 Amid Steady Gains